IDiyas

For the Inventor, By the Inventor

Lansdale, PA, United States of America

David E McClure

USPTO Granted Patents = 20

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 128(Granted Patents)


Location History:

  • Hatfield, PA (US) (1980 - 1982)
  • Lansdale, US (1984)
  • Lansdale, PA (US) (1982 - 1989)

Company Filing History:

goldMedal19 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal2 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal1 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1980-1989

Loading Chart...
20 patents (USPTO):Explore Patents
1. 4816457 - Aralkylaminoethanol heterocyclic compounds (1989-03-28),
2. 4686222 - Aralkylaminoethanol heterocyclic compounds (1987-08-11),
3. 4677102 - Substituted diazapines and derivatives thereof useful in the treatment (1987-06-30),
4. 4677101 - Substituted dihydroazepines useful as calcium channel blockers (1987-06-30),
5. 4675321 - Substituted pyrimidines useful as calcium channel blockers (1987-06-23),
6. 4656168 - (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of (1987-04-07),
7. 4609494 - 5-acetyl-3,4,5,6-tetrahydro-4-oxo-2,6-methano-2H-1,3,5-benzothiazoci (1986-09-02),
8. 4588824 - Preparation of epihalohydrin enantiomers (1986-05-13),
9. 4568679 - Aralkylaminoethanol heterocyclic compounds (1986-02-04),
10. 4533745 - Amino ketones and their preparation (1985-08-06),
11. 4486446 - Aralkylaminoethanol heterocyclic compounds (1984-12-04),
12. 4472427 - (Aralkylamino-2-OR-propoxy)heterocyclic compounds (1984-09-18),
13. 4442094 - (3-Aralkylamino-2-or-propoxy)heterocyclic compounds (1984-04-10),
14. 4431647 - Method of use of enantiomers of trans-indeno[1,2-b]-1,4-oxazines (1984-02-14),
15. 4408063 - Preparation of epihalohydrin enantiomers (1983-10-04),

Title: Innovations and Achievements of David E. McClure

Introduction

David E. McClure, based in Lansdale, PA, has made significant contributions to the field of innovation, holding an impressive portfolio of 20 patents. His work primarily focuses on the development of new chemical compounds that have practical applications in various industries.

Latest Patents

Among his latest patents, David McClure has developed Aralkylaminoethanol heterocyclic compounds, specifically heterocyclic aminoethanols characterized by their unique formula. These innovations exhibit potential applications in pharmaceuticals and chemical processes, showcasing David's talent for addressing complex scientific challenges.

Career Highlights

David's career has been marked by notable positions at prestigious firms, including Merck & Company, Inc. and Merck Sharp & Dohme Corporation. His work with these organizations has enabled significant advancements in the pharmaceutical industry, where he has been instrumental in driving research and development efforts.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues, including John J. Baldwin and Joseph G. Atkinson. These professional partnerships have not only fostered innovation but have also contributed to the successful implementation of various research projects.

Conclusion

In conclusion, David E. McClure exemplifies the spirit of innovation through his substantial contributions to the field of chemistry and medicine. His numerous patents and collaborative efforts highlight his dedication to advancing technology for the benefit of society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…